GPRC5D x CD3 drugs for Multiple Myeloma
4 tracked GPRC5D x CD3 drugs in the Multiple Myeloma race. The class explanation lives on the GPRC5D x CD3 page; the full indication pipeline across every mechanism is on the Multiple Myeloma page.
1 approved / phase 41 Phase 31 Phase 1/21 Phase 1